Understanding the mechanisms of these three cytokines and their complex roles within the TME and the immune landscape is critical for developing therapeutics that promote anti-tumor responses by influencing dynamics between IL-27, IL-30, and IL-35. The gene discussed is IL27; the disease is neoplasm.